Photographic Memory: Wearable Cam Could Help Patients Stave Off Effects of Impaired Recall
Monday, October 31, 2011 - 16:30
in Health & Medicine
Hopes for new Alzheimer's drugs that would slow or stop the disease's inexorable decline have repeatedly foundered in recent years. Large pharmaceutical companies, which have pushed ahead with drugs that stop the buildup of toxic proteins that damage and kill brain cells, have reported a recurring string of bad news. Just one example: Eli Lilly had to suspend last year the trial of a pharmaceutical designed to prevent the production of the toxic amyloid-beta protein because patients' cognition actually worsened on the drug. [More]